The Hirshberg Foundation is excited to have Matt Lashey joining us at the 14th Annual Symposium on Pancreatic Cancer to share how the newly created app, chemoWave, can help cancer patients when they document their patient experience.
A free new mobile app, chemoWave, from parent company Treatment Technologies and Insights (TTI), was created with a mission to improve the patient experience and harness the power of patient reported outcomes (PROs).
When Matt’s partner was diagnosed with cancer and they couldn’t find a comprehensive tool to help navigate treatment, Lashey drew from his extensive experience with strategic research and data analysis to create his own. At the encouragement of their doctor, Lashey began developing chemoWave to enable patients to be better partners with their care providers.
The chemoWave technology not only tracks the full treatment experience outside the clinical setting (including medications, meals, symptoms, side effects and other activities), it also analyzes the resulting patterns and provides on-going actionable insights & tips to users. The result for patients is propelling them to do more of what makes them feel better and less of what makes them feel worse; The result for care teams is improved quality, effectiveness and efficiency of cancer care.
Prior to TTI, Matt Lashey served as acting SVP of Primary Research for Discovery Networks. Lashey also served as Vice President of Innovation Insights and Business Leadership at the consulting firm Maddock Douglas. Prior to that, he was VP of Strategic Insights for Lifetime Networks and A&E Television’s Digital Assets. Mr. Lashey received his MBA from Columbia Business School, after a successful career as a Broadway actor.
Matt Lashey will speak on how chemoWave enables Chemo Patients to Take Control.
